Elite in Osteolysis Syndrome Recessive

Dr. Michael A. Mont

Orthopedics
Sinai Hospital Of Baltimore, Inc
5401 Old Court Rd, 
Randallstown, MD 
Elite in Osteolysis Syndrome Recessive
Sinai Hospital Of Baltimore, Inc
5401 Old Court Rd, 
Randallstown, MD 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Michael Mont is an Orthopedics provider in Randallstown, Maryland. Dr. Mont is rated as an Elite provider by MediFind in the treatment of Osteolysis Syndrome Recessive. His top areas of expertise are Osteonecrosis, Osteoarthritis, Osteolysis Syndrome Recessive, Knee Replacement, and Hip Replacement.

His clinical research consists of co-authoring 1215 peer reviewed articles and participating in 10 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 12 articles in the study of Osteolysis Syndrome Recessive.

Specialties
Orthopedics
Licenses
Adult Reconstructive Orthopaedic Surgery in OH
Hospital Affiliations
Sinai Hospital Of Baltimore
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D

Locations

SINAI HOSPITAL OF BALTIMORE, INC
5401 Old Court Rd, Randallstown, MD 21133

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

10 Clinical Trials

A Phase 3 Prospective, Multicenter, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Efficacy of Amniotic Suspension Allograft (ASA) in Patients With Osteoarthritis of the Knee
A Phase 3 Prospective, Multicenter, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Efficacy of Amniotic Suspension Allograft (ASA) in Patients With Osteoarthritis of the Knee
Enrollment Status: Active_not_recruiting
Publish Date: March 21, 2025
Intervention Type: Biological, Drug
Study Drug: Amniotic Fluid
Study Phase: Phase 3
Comparative Effectiveness of Pulmonary Embolism Prevention After Hip and Knee Replacement: Balancing Safety and Effectiveness
Comparative Effectiveness of Pulmonary Embolism Prevention After Hip and Knee Replacement: Balancing Safety and Effectiveness
Enrollment Status: Active_not_recruiting
Publish Date: January 22, 2025
Intervention Type: Drug
Study Drugs: Enteric Coated Aspirin, Warfarin, Rivaroxaban
Study Phase: Phase 4
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Phase 3 Study to Determine the Efficacy of TG-C in Subjects with Kellgren and Lawrence Grade (KLG) 2 or 3 Osteoarthritis of the Knee
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Phase 3 Study to Determine the Efficacy of TG-C in Subjects with Kellgren and Lawrence Grade (KLG) 2 or 3 Osteoarthritis of the Knee
Enrollment Status: Active_not_recruiting
Publish Date: December 11, 2024
Intervention Type: Biological
Study Drug: TissueGene-C
Study Phase: Phase 3
A Prospective, Post-market, Multi-center Study of the Trident II Tritanium Acetabular Shell
A Prospective, Post-market, Multi-center Study of the Trident II Tritanium Acetabular Shell
Enrollment Status: Active_not_recruiting
Publish Date: December 04, 2024
Intervention Type: Device
Study Phase: Not Applicable
Triathlon Tritanium Knee Outcomes Study
Triathlon Tritanium Knee Outcomes Study
Enrollment Status: Terminated
Publish Date: November 14, 2023
Intervention Type: Device
Study Phase: Not Applicable
PILOT STUDY: Gait and Functional Improvement in Total Knee Arthroplasty With the Use of Verasense for Soft Tissue Balancing: A Randomized, Double-Blind, Controlled Trial
PILOT STUDY: Gait and Functional Improvement in Total Knee Arthroplasty With the Use of Verasense for Soft Tissue Balancing: A Randomized, Double-Blind, Controlled Trial
Enrollment Status: Terminated
Publish Date: February 06, 2023
Intervention Type: Device, Procedure
Study Phase: Not Applicable
A Multicenter, Double-blind, Randomized, Sham-controlled Study Assessing Opioid Utilization, Postoperative Pain and Function in Subjects Undergoing Total Knee Arthroplasty Treated With Presurgical Iovera®° or Sham Iovera®° Cryoneurolysis and Postsurgical Multimodal Pain Regimen
A Multicenter, Double-blind, Randomized, Sham-controlled Study Assessing Opioid Utilization, Postoperative Pain and Function in Subjects Undergoing Total Knee Arthroplasty Treated With Presurgical Iovera®° or Sham Iovera®° Cryoneurolysis and Postsurgical Multimodal Pain Regimen
Enrollment Status: Terminated
Publish Date: January 25, 2023
Intervention Type: Device
Study Phase: Not Applicable
Prospective Randomized Trial of Dermabond Prineo Wound Closure System on Operating Room Time and Wound Closure Time in Total Knee Arthroplasty
Prospective Randomized Trial of Dermabond Prineo Wound Closure System on Operating Room Time and Wound Closure Time in Total Knee Arthroplasty
Enrollment Status: Completed
Publish Date: May 13, 2021
Intervention Type: Device
Study Phase: Not Applicable
The Use of STRATAFIX Suture Device Compared to Standard-of-care for Deep Tissue Closure in Total Knee Arthroplasty
The Use of STRATAFIX Suture Device Compared to Standard-of-care for Deep Tissue Closure in Total Knee Arthroplasty
Enrollment Status: Completed
Publish Date: November 19, 2020
Intervention Type: Device
Study Phase: Not Applicable
Prospective Randomized Trial of Stratafix vs. Vicryl on Operating Room Time and Wound Closure Time in Total Hip Arthroplasty.
Prospective Randomized Trial of Stratafix vs. Vicryl on Operating Room Time and Wound Closure Time in Total Hip Arthroplasty.
Enrollment Status: Completed
Publish Date: November 17, 2020
Intervention Type: Device
Study Phase: Not Applicable
View 9 Less Clinical Trials

1212 Total Publications

Glucagon-Like Peptide-1 Receptor Agonists: Have We Found the Holy Grail for Total Joint Arthroplasty?
Glucagon-Like Peptide-1 Receptor Agonists: Have We Found the Holy Grail for Total Joint Arthroplasty?
Journal: The Journal of arthroplasty
Published: October 16, 2025
Similar Doctors
Advanced in Osteolysis Syndrome Recessive
Dr. Surena Namdari
Orthopedics
Advanced in Osteolysis Syndrome Recessive
Dr. Surena Namdari
Orthopedics

Blue Hen Physical Therapy Inc

425 New London Rd, 
Newark, DE 
 (58.9 miles away)
302-453-1588
Languages Spoken:
English
See accepted insurances

Surena Namdari is an Orthopedics provider in Newark, Delaware. Dr. Namdari is rated as a Distinguished provider by MediFind in the treatment of Osteolysis Syndrome Recessive. His top areas of expertise are Tendinitis, Osteoarthritis, Osteolysis Syndrome Recessive, Endoscopy, and Osteotomy.

Advanced in Osteolysis Syndrome Recessive
Dr. Philip K. Mcclure
Orthopedics | Pediatric Orthopedics
Advanced in Osteolysis Syndrome Recessive
Dr. Philip K. Mcclure
Orthopedics | Pediatric Orthopedics

Sinai Hospital Of Baltimore, Inc

2401 E Belvedere Ave, 
Baltimore, MD 
 (5.3 miles away)
Experience:
16+ years
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Philip Mcclure is an Orthopedics specialist and a Pediatric Orthopedics provider in Baltimore, Maryland. Dr. Mcclure has been practicing medicine for over 16 years and is rated as a Distinguished provider by MediFind in the treatment of Osteolysis Syndrome Recessive. His top areas of expertise are Clubfoot, Congenital Femoral Deficiency, Claw Foot, Osteotomy, and Bone Graft. Dr. Mcclure is currently accepting new patients.

Advanced in Osteolysis Syndrome Recessive
Dr. John E. Herzenberg
Orthopedics
Advanced in Osteolysis Syndrome Recessive
Dr. John E. Herzenberg
Orthopedics
2401 W Belvedere Avenue, Rubin Institute For Advanced Orthopedics, 
Baltimore, MD 
 (6.4 miles away)
410-601-8700
Languages Spoken:
English
See accepted insurances

John Herzenberg is an Orthopedics provider in Baltimore, Maryland. Dr. Herzenberg is rated as an Elite provider by MediFind in the treatment of Osteolysis Syndrome Recessive. His top areas of expertise are Congenital Femoral Deficiency, Clubfoot, Absence of Tibia, Tenotomy, and Osteotomy.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Mont's expertise for a condition
ConditionClose
View All 7 Elite Conditions
View All 8 Distinguished Conditions
View All 18 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile